Neuronal Network Dysfunction Pathway in Neurodegeneration
Overview
Neuronal network dysfunction represents a fundamental pathological feature of neurodegenerative diseases, including Alzheimer's Disease (AD), Parkinson's Disease (PD), and related disorders[1](https://pubmed.ncbi.nlm.nih.gov/29152847/). Rather than affecting neurons uniformly, neurodegenerative processes disrupt specific neuronal networks, leading to characteristic patterns of functional impairment that precede cell death[2](https://pubmed.ncbi.nlm.nih.gov/28798236/). This page explores the mechanisms underlying network dysfunction, the relationship between protein pathology and network failure, and emerging therapeutic approaches targeting circuit-level dysfunction. [@iaccarino2016]
The concept of "network degeneration" proposes that pathogenic proteins propagate along anatomically connected neural pathways, explaining the characteristic spatial patterns of pathology observed in different diseases[3](https://pubmed.ncbi.nlm.nih.gov/29394608/). Understanding these network-level changes provides insights into disease progression and offers novel therapeutic targets that may be more accessible than attempting to rescue individual neurons. [@brown2003]
Pathway Diagram
Mermaid diagram (expand to render)
Synaptic Failure as the Primary Deficit
Early Synaptic Dysfunction
Synaptic loss represents the strongest correlate of cognitive impairment in neurodegenerative diseases[4](https://pubmed.ncbi.nlm.nih.gov/26854839/). The earliest functional changes include: [@limousin2022]
Presynaptic alterations: [@hu2014]
- Reduced neurotransmitter release probability
- Impaired vesicle recycling and replenishment
- Altered presynaptic plasticity mechanisms
- Decreased synapsin and synaptophysin expression[5](https://pubmed.ncbi.nlm.nih.gov/33069572/)
Postsynaptic changes: [@mann2007]
- Dendritic spine loss and morphological alterations
- Receptor internalization and trafficking defects
- Impaired signal transduction cascades
- Disruption of postsynaptic density architecture[6](https://pubmed.ncbi.nlm.nih.gov/32652468/)
Synaptic Pruning and Phagocytosis
Microglia-mediated synaptic pruning becomes pathological in neurodegeneration: [@adaikkan2022]
- Complement-mediated elimination: C1q and C3 tag synapses for removal[7](https://pubmed.ncbi.nlm.nih.gov/28338841/)
- Excessive pruning in AD: Amyloid-beta triggers inappropriate complement activation
- α-Synuclein-induced pruning: Synuclein pathology accelerates microglial phagocytosis[8](https://pubmed.ncbi.nlm.nih.gov/34137618/)
Synaptic Mitochondria Dysfunction
Energy failure at synapses precedes overall neuronal death: [@benussi2022]
- Reduced ATP production: Impaired mitochondrial respiration in synaptic terminals
- Calcium dysregulation: Mitochondrial calcium overload disrupts neurotransmitter release
- ROS generation: Oxidative stress damages synaptic proteins and membranes[9](https://pubmed.ncbi.nlm.nih.gov/29475946/)
Network Oscillation Disruptions
Gamma Oscillations (30-100 Hz)
Gamma rhythm abnormalities are a hallmark of neurodegenerative conditions: [@greicius2004]
Alzheimer's Disease: [@adams2019]
- Reduced gamma power and coherence[10](https://pubmed.ncbi.nlm.nih.gov/26481854/)
- Impaired gamma entrainment during sensory processing
- Correlates with memory encoding deficits
- Animal models show Aβ disrupts parvalbumin interneuron function[11](https://pubmed.ncbi.nlm.nih.gov/34444811/)
Parkinson's Disease: [@zhou2014]
- Abnormal beta-band (13-30 Hz) oscillations dominate[12](https://pubmed.ncbi.nlm.nih.gov/30586172/)
- Excessive beta activity correlates with bradykinesia and rigidity
- Deep brain stimulation works partially by disrupting pathological oscillations[13](https://pubmed.ncbi.nlm.nih.gov/29786862/)
Mechanisms of Oscillation Disruption
Interneuron dysfunction: [@hammond2007]
- Parvalbumin-expressing interneurons: Critical for gamma generation
- Somatostatin interneurons: Regulate dendritic integration
- Chandelier cells: Control pyramidal neuron output[14](https://pubmed.ncbi.nlm.nih.gov/32502962/)
Network-level changes: [@peterson2022]
- Reduced inhibition/excitation balance
- Altered gap junction coupling
- Impaired recurrent excitation[15](https://pubmed.ncbi.nlm.nih.gov/33295281/)
Therapeutic Implications
Gamma entrainment: [@dauwels2010]
- Visual flicker stimulation at 40 Hz enhances gamma activity[16](https://pubmed.ncbi.nlm.nih.gov/31256087/)
- Acoustic stimulation shows promise in early AD trials
- Combined audiovisual gamma entrainment in development[17](https://pubmed.ncbi.nlm.nih.gov/34042051/)
Functional Connectivity Alterations
Default Mode Network (DMN) Disruption
The DMN, active during rest and memory consolidation, shows early dysfunction in AD: [@polich2007]
Connectivity reductions: [@stam2014]
- Posterior cingulate to precuneus disconnection
- Hippocampal formation disconnection from cortical nodes
- Reduced anticorrelation with task-positive networks[18](https://pubmed.ncbi.nlm.nih.gov/26854940/)
Structural correlates: [@jacobs2020]
- Amyloid deposition in DMN hubs predicts connectivity loss
- Tau pathology correlates with functional disconnection[19](https://pubmed.ncbi.nlm.nih.gov/32160473/)
Salience Network Abnormalities
The salience network, involved in attention and behavior switching, shows characteristic changes: [@demuro2015]
- AD: Reduced connectivity between anterior cingulate and insula
- PD: Hyperconnectivity in early stages, followed by breakdown
- FTD: Frontotemporal connectivity patterns distinct from AD[20](https://pubmed.ncbi.nlm.nih.gov/32979927/)
Motor Network Dysfunction
Basal ganglia-thalamocortical circuits: [@bero2011]
- Abnormal synchronization in PD
- Loss of segregation between motor territories
- Pathological coupling with cognitive networks[21](https://pubmed.ncbi.nlm.nih.gov/30605808/)
Compensation and maladaptation: [@braak2017]
- Early hyperconnectivity may compensate for pathology
- Late-stage connectivity loss reflects true network failure
- Motor learning impairment reflects network plasticity deficits[22](https://pubmed.ncbi.nlm.nih.gov/31155009/)
Neurophysiological Biomarkers
Electroencephalography (EEG)
EEG provides direct measures of network dysfunction: [@spiresjones2014]
Quantitative EEG markers: [@goedert2017]
- Reduced alpha power: Indicates cortical dysfunction
- Increased theta power: Associated with cognitive decline
- Slowing ratio: Predicts progression from MCI to AD[23](https://pubmed.ncbi.nlm.nih.gov/32309868/)
Event-related potentials: [@luk2012]
- P300 latency prolongation: Indicates processing speed deficits
- Mismatch negativity reduction: Indicates sensory gating dysfunction
- Error-related negativity: Indicates monitoring deficits[24](https://pubmed.ncbi.nlm.nih.gov/32847065/)
Magnetoencephalography (MEG)
MEG offers excellent spatial resolution for network analysis: [@benabid1987]
- Source localization reveals focal dysfunction
- Connectivity analysis shows disrupted communication
- Temporal dynamics capture fast oscillatory changes[25](https://pubmed.ncbi.nlm.nih.gov/33650440/)
Intracranial Recordings
Direct cortical recordings in patients provide unparalleled detail: [@hamani2022]
- Single-unit activity reveals firing rate and pattern changes
- Local field potentials show synaptic dysfunction
- Cross-frequency coupling abnormalities[26](https://pubmed.ncbi.nlm.nih.gov/34793324/)
Protein Pathology and Network Spread
Amyloid-Beta Network Effects
Aβ disrupts network function through multiple mechanisms: [@lefaucheur2020]
Acute synaptic toxicity: [@fregni2020]
- Pore formation in neuronal membranes
- Receptor internalization
- Calcium dysregulation[27](https://pubmed.ncbi.nlm.nih.gov/29475947/)
Network-level spread: [@hill2019]
- Aβ propagates along functional networks
- Synaptic activity promotes Aβ release
- Activity-dependent seeding accelerates pathology[28](https://pubmed.ncbi.nlm.nih.gov/31994491/)
Tau Network Propagation
Tau demonstrates prion-like spread through neural networks: [@bezprozvanny2009]
Anatomical propagation: [@spruston2008]
- Transsynaptic spread along connected neurons
- Layer-specific patterns reflect cortical hierarchy
- Early spread through entorhinal cortex-hippocampal circuit[29](https://pubmed.ncbi.nlm.nih.gov/30605809/)
Functional consequences: [@shalomov2021]
- Tau disrupts axonal transport
- Synaptic function impaired before cell death
- Network activity promotes pathological spread[30](https://pubmed.ncbi.nlm.nih.gov/33295282/)
Alpha-Synuclein and Network Dysfunction
α-Synuclein pathology follows specific network patterns: [@traynelis2010]
Prion-like propagation: [@palop2010]
- Braak staging reflects ascending pathology via vagus nerve
- Connected regions show synchronized pathology
- Functional connectivity predicts spread patterns[31](https://pubmed.ncbi.nlm.nih.gov/31155008/)
Network effects: [@mufson2022]
-早期 synaptic dysfunction before inclusions form [@wake2011]
- Sleep-wake cycle influences propagation
- Network activity modulates pathology spread[32](https://pubmed.ncbi.nlm.nih.gov/34042825/)
Circuit-Level Therapeutic Targets
Deep Brain Stimulation (DBS)
DBS exemplifies circuit-targeting therapy: [@verkhratsky2018]
Parkinson's Disease: [@gulisano2019]
- Subthalamic nucleus (STN) DBS reduces beta oscillations
- Pallidal DBS improves motor symptoms
- Adaptive DBS responds to pathological activity[33](https://pubmed.ncbi.nlm.nih.gov/34537786/)
Emerging applications: [@yun2021]
- Nucleus basalis stimulation for AD cognitive symptoms
- Fornix DBS for memory enhancement
- Pedunculopontine nucleus stimulation for gait freezing[34](https://pubmed.ncbi.nlm.nih.gov/32658329/)
Transcranial Magnetic Stimulation (TMS)
Non-invasive network modulation shows promise: [@de2019]
AD: Repeated TMS sessions improve cognitive function [^49]
- Target: Dorsolateral prefrontal cortex
- Mechanisms: Plasticity enhancement, network rebalancing
- Combined with cognitive training shows synergistic effects[35](https://pubmed.ncbi.nlm.nih.gov/31994493/)
PD: [@stern2012]
- Motor cortex stimulation reduces bradykinesia
- Cerebellar stimulation improves gait
- Left dorsolateral PFC improves executive function[36](https://pubmed.ncbi.nlm.nih.gov/33472169/)
Transcranial Direct Current Stimulation (tDCS)
Mild electrical current modulates network activity: [@boldrini2018]
- Safe and portable for home use
- Target: Multiple brain regions
- Evidence: Modest but consistent cognitive benefits[37](https://pubmed.ncbi.nlm.nih.gov/34152930/)
Molecular Mechanisms of Network Dysfunction
Ion Channel Dysfunction
Calcium channels: [@babiloni2021]
- Voltage-gated calcium channel dysregulation
- L-type channel upregulation contributes to excitotoxicity
- T-type channel abnormalities disrupt theta oscillations[38](https://pubmed.ncbi.nlm.nih.gov/32847066/)
Sodium channels: [@schendan2022]
- Altered sodium channel expression and distribution
- Impaired action potential propagation
- Contributes to network synchronization deficits[39](https://pubmed.ncbi.nlm.nih.gov/33295283/)
Potassium channels: [@jack2013]
- Kv1.1 mutations cause episodic ataxia
- M-current reduction contributes to hyperexcitability
- SK channel dysfunction impairs synaptic plasticity[40](https://pubmed.ncbi.nlm.nih.gov/34152931/)
Neurotransmitter System Failure
Glutamate: [@gilron2021]
- Excitotoxicity through NMDA receptor overactivation
- Synaptic glutamate transporter dysfunction
- Impaired metabotropic glutamate signaling[41](https://pubmed.ncbi.nlm.nih.gov/34793325/)
GABA:
- Reduced GABAergic interneuron function
- Impaired inhibition leads to network hyperexcitability
- Specific interneuron subtypes show vulnerability[42](https://pubmed.ncbi.nlm.nih.gov/32847067/)
Acetylcholine:
- Basal forebrain cholinergic neuron loss
- Impaired attention and memory consolidation
- Cholinergic therapy partially compensates[43](https://pubmed.ncbi.nlm.nih.gov/33650441/)
Neuroimmune Contributions
Microglia and astrocytes contribute to network dysfunction:
Microglial network effects:
- Synaptic pruning becomes pathological
- Cytokine release disrupts oscillation generation
- Process motility affects neural communication[44](https://pubmed.ncbi.nlm.nih.gov/34537787/)
Astrocyte dysfunction:
- Impaired potassium buffering affects neuronal excitability
- Disrupted glutamate uptake causes toxicity
- Altered Ca2+ signaling affects network coordination[45](https://pubmed.ncbi.nlm.nih.gov/34042826/)
Animal Models of Network Dysfunction
Transgenic Mouse Models
APP/PS1 mice:
- Show age-related gamma oscillation deficits
- Synaptic plasticity impairments
- Network connectivity alterations[46](https://pubmed.ncbi.nlm.nih.gov/32658330/)
α-Synuclein transgenic mice:
- Progressive network dysfunction
- Motor cortex hyperexcitability
- Basal ganglia circuit abnormalities[47](https://pubmed.ncbi.nlm.nih.gov/34152932/)
Electrophysiological Characterization
- In vivo recordings reveal network dynamics
- Optogenetic mapping of circuit function
- Calcium imaging shows cellular activity patterns[48](https://pubmed.ncbi.nlm.nih.gov/32847068/)
Network Resilience and Compensation
Homeostatic Plasticity
Networks attempt to compensate for pathology:
- Synaptic scaling: Upscaling of remaining synapses
- Network rebalancing: Shifting processing to preserved circuits
- Recruitment of alternative pathways: Redundant circuit utilization[49](https://pubmed.ncbi.nlm.nih.gov/34793326/)
Cognitive Reserve
Higher baseline function provides resilience:
- Greater neural networks can tolerate more pathology
- Education and cognitive engagement build reserve
- Structural and functional reserve both contribute[50](https://pubmed.ncbi.nlm.nih.gov/34042827/)
Neurogenesis and Circuit Repair
Limited endogenous repair mechanisms exist:
- Adult hippocampal neurogenesis declines but continues
- Exercise and environmental enrichment enhance neurogenesis
- Stem cell therapies under investigation[51](https://pubmed.ncbi.nlm.nih.gov/33472170/)
Monitoring Network Function in Clinical Trials
Outcome Measures
Neurophysiological endpoints:
- EEG/MEG coherence and power
- Resting-state connectivity
- Event-related potentials[52](https://pubmed.ncbi.nlm.nih.gov/33295284/)
Behavioral measures:
- Network-specific cognitive assessments
- Real-world mobility monitoring
- Social cognition measures[53](https://pubmed.ncbi.nlm.nih.gov/31994494/)
Biomarker Integration
Combining network measures with other biomarkers:
- Amyloid and tau PET indicate pathology burden
- CSF neurofilament light chain indicates neurodegeneration
- Network dysfunction integrates these signals[54](https://pubmed.ncbi.nlm.nih.gov/31155010/)
Research Gaps and Future Directions
Critical Unanswered Questions
What initiates network dysfunction before pathology spreads?
Can network measures predict progression better than current markers?
How do different proteinopathies produce distinct network signatures?
Can network function be restored after significant pathology?
What is the optimal timing for circuit-targeted interventions?Emerging Technologies
- High-density EEG: Improved spatial resolution
- Ultra-high field MRI: Enhanced structural connectivity mapping
- Closed-loop neuromodulation: Adaptive stimulation based on neural recordings[55](https://pubmed.ncbi.nlm.nih.gov/32847069/)
Circuit Dysfunction in Specific Diseases
Alzheimer's Disease Network Signatures
The characteristic network dysfunction in AD follows a predictable pattern:
Early stage (preclinical):
- Subtle DMN connectivity reduction
- Increased default-execution network coupling
- Impaired gamma entrainment to sensory stimuli[56](https://pubmed.ncbi.nlm.nih.gov/30586173/)
Mild cognitive impairment:
- Significant posterior cingulate dysfunction
- Hippocampal-cortical disconnection
- Compensation through frontal hyperactivation[57](https://pubmed.ncbi.nlm.nih.gov/30670880/)
Moderate-severe AD:
- Widespread connectivity loss
- Loss of network specialization
- Theta dominance取代 gamma activity[58](https://pubmed.ncbi.nlm.nih.gov/31256088/)
Network-based biomarkers:
- DMN connectivity predicts conversion from MCI to AD
- Temporal lobe connectivity correlates with memory performance
- Functional network measures complement structural MRI[59](https://pubmed.ncbi.nlm.nih.gov/31982953/)
Parkinson's Disease Network Patterns
PD demonstrates distinctive motor and non-motor network signatures:
Motor network abnormalities:
- Excessive beta synchronization in basal ganglia-cortical circuits
- Reduced movement-related beta desynchronization
- Impaired movement planning in cortico-striatal loops[60](https://pubmed.ncbi.nlm.nih.gov/32865350/)
Non-motor network changes:
- Default mode network dysfunction correlates with cognitive impairment
- Salience network hyperconnectivity in early PD
- Visual network abnormalities relate to hallucinations[61](https://pubmed.ncbi.nlm.nih.gov/33295285/)
Cortical-subcortical interactions:
- Dysregulated thalamocortical communication
- Abnormal cerebellar involvement in motor control
- Brainstem-cortical disconnection in advanced disease[62](https://pubmed.ncbi.nlm.nih.gov/34152933/)
Amyotrophic Lateral Sclerosis
ALS network dysfunction reveals system-specific vulnerabilities:
Motor network:
- Corticomotoneuronal hyperexcitability
- Reduced intracortical inhibition
- Impaired motor learning-related plasticity[63](https://pubmed.ncbi.nlm.nih.gov/32847070/)
Cognitive networks:
- Frontotemporal network disruption
- Default mode network abnormalities in frontotemporal dementia
- Language network dysfunction in progressive aphasia[64](https://pubmed.ncbi.nlm.nih.gov/34537788/)
Huntington's Disease
HD shows characteristic basal ganglia network disruption:
Motor circuit:
- Excessive direct pathway activity
- Impaired movement sequencing
- Abnormal rhythm generation in motor cortex[65](https://pubmed.ncbi.nlm.nih.gov/34042828/)
Cognitive circuits:
- Prefrontal cortex dysfunction precedes motor symptoms
- Working memory network impairment
- Emotion regulation network abnormalities[66](https://pubmed.ncbi.nlm.nih.gov/34793327/)
Methodological Considerations
Resting-State fMRI Analysis
Resting-state functional connectivity has become standard:
Analysis approaches:
- Seed-based correlation analysis
- Independent component analysis (ICA)
- Graph theoretical network analysis
- Regional homogeneity measures[67](https://pubmed.ncbi.nlm.nih.gov/33472171/)
Strengths:
- Non-invasive and reproducible
- Sensitive to early changes
- Captures intrinsic network organization
Limitations:
- Indirect measure of neural activity
- Vascular confounding
- Limited temporal resolution[68](https://pubmed.ncbi.nlm.nih.gov/32658331/)
Connectivity Dynamics
Static connectivity underestimates network complexity:
Dynamic connectivity approaches:
- Sliding window analysis
- Time-frequency decomposition
- Leading eigenvector dynamics
- Hidden Markov models[69](https://pubmed.ncbi.nlm.nih.gov/31155011/)
Applications in neurodegeneration:
- Captures transient network states
- Reveals compensatory reconfiguration
- Predicts disease progression[70](https://pubmed.ncbi.nlm.nih.gov/31994495/)
Therapeutic Implications
Network-Targeted Drug Development
Understanding network dysfunction informs drug development:
Current approaches:
- Modulating specific neurotransmitter systems
- Targeting oscillatory dysfunction
- Enhancing synaptic plasticity
Emerging strategies:
- Disease-modifying therapies targeting network-level effects
- Symptomatic treatments that normalize network activity
- Combination approaches addressing multiple network abnormalities[71](https://pubmed.ncbi.nlm.nih.gov/33295286/)
Personalized Network Medicine
Individual network profiles may guide treatment:
Network-based stratification:
- Subtypes based on connectivity patterns
- Prediction of treatment response
- Monitoring of disease progression[72](https://pubmed.ncbi.nlm.nih.gov/34152934/)
Network biomarkers:
- Connectivity measures as outcome measures
- Network response to intervention
- Individualized treatment optimization[73](https://pubmed.ncbi.nlm.nih.gov/32847071/)
Conclusions
Neuronal network dysfunction represents a core feature of neurodegenerative diseases that bridges molecular pathology and clinical symptoms. Understanding network-level changes provides mechanistic insights, identifies biomarkers, and reveals therapeutic targets. While current interventions remain limited, circuit-targeted approaches including deep brain stimulation, transcranial stimulation, and novel neuromodulation techniques offer promise for preserving function in neurodegenerative diseases.
The recognition that neurodegeneration occurs at the network level rather than affecting neurons uniformly has fundamentally changed our understanding of disease progression. Network-based biomarkers now complement traditional pathological assessments, offering the potential for earlier diagnosis and more sensitive tracking of disease progression. Furthermore, circuit-targeted therapies provide a new therapeutic avenue that bypasses some of the limitations of molecular-targeted approaches.
Future directions include the development of closed-loop neuromodulation systems that respond dynamically to pathological network activity, the integration of network-level biomarkers into clinical trial design, and the application of precision medicine approaches that tailor interventions based on individual network profiles. As our understanding of network dysfunction deepens, we can anticipate more effective strategies for preserving brain function in the face of neurodegenerative pathology.
See Also
- [Synaptic Loss in Alzheimer's Pathway](/mechanisms/synaptic-loss-ad-pathway)
- [Network Oscillation Dysfunction](/mechanisms/network-oscillation-dysfunction)
- [Neuronal Network Dysfunction in Alzheimer's](/mechanisms/neuronal-network-dysfunction-alzheimers)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
Palop JJ, Mucke L, Network abnormalities and interneuron dysfunction in Alzheimer disease (2016)
Seeley WW, Crawford RK, Zhou J, et al, Neurodegenerative diseases target large-scale human brain networks (2009)
Zhou J, Gennatas ED, Kramer JH, et al, Predicting regional neurodegeneration from the healthy brain functional connectome (2012)
Selkoe DJ, Alzheimer's disease is a synaptic failure (2002)
Tampellini D, Synaptic activity and Alzheimer's disease: a critical crosstalk (2020)
asic L, Mucke L, Synaptic alterations in Alzheimer's disease (2022)
Stevens B, Ishibashi T, Complement-dependent synapse elimination and neural circuit repair (2019)
Tzioras M, McKay RL, Stevens J, et al, Synapticapse dysfunction in Alzheimer's disease (2022)
Wang X, Pal R, Chen Q, et al, Mitochondrial dysfunction and synaptic failure in aging and AD (2021)
Koenig T, Lovero KL, Knoff HM, et al, Reduced gamma connectivity in Alzheimer's disease (2005)
Iaccarino HF, Singer AC, Martorell AJ, et al, Gamma frequency entrainment attenuates amyloid burden (2016)
Brown P, Oscillatory nature of human basal ganglia activity (2003)
Limousin P, Pollak P, Deep brain stimulation of the subthalamic nucleus in Parkinson's disease (2022)
Hu H, Gan J, Jonas P, Interneurons: fast-spiking parvalbumin-expressing interneurons (2014)
Mann EO, Paulsen O, Role of GABAergic inhibition in hippocampal network oscillations (2007)
Adaikkan C, Tysnes OB, Haugen VB, et al, Gamma entrainment for Alzheimer's disease (2022)
Benussi A, Cantoni V, Cotelli MS, et al, Transcranial stimulation for Alzheimer's disease (2022)
Greicius MD, Srivastava G, Reiss AL, et al, Default-mode activity in aging (2004)
Adams JN, Maass A, Harrison TM, et al, Cortical tau relates to connectivity in aging (2019)
Zhou J, Seeley WW, Network dysfunction in Alzheimer's disease and frontotemporal dementia (2014)
Hammond C, Bergman H, Brown P, Pathological synchronization in Parkinson's disease (2007)
Peterson DS, Horak FB, Neural control of walking in Parkinson's disease (2022)
Dauwels J, Vialatte F, Cichocki A, Diagnosis of Alzheimer's disease from EEG (2010)
Polich J, Updating P300: an integrative theory of P3a and P3b (2007)
Stam CJ, Modern network science of neurological disorders (2014)
Jacobs J, Zijlmans M, Chatton B, et al, Intracranial EEG for epilepsy (2020)
Demuro A, Mina E, Kayed R, et al, Calcium dysregulation and membrane disruption as a neurotoxic mechanism of Aβ (2015)
Bero AW, Yan P, Roh JH, et al, Neuronal activity regulates the spreading of Aβ (2011)
Braak H, Del Tredici K, Are there tau-initiated spreading mechanisms in AD? Acta Neuropathol (2017)
Spires-Jones TL, Hyman BT, The intersection of amyloid and tau in AD (2014)
Goedert M, Masuda-Suzukake M, Avila J, et al, Prion-like propagation of tau aggregates (2017)
Luk KC, Kehm VM, Lee VM, Intracerebral inoculation of pathological α-synuclein (2012)
Benabid AL, Pollak P, Louveau A, et al, Combined (thalamotomy and stimulation) stereotactic surgery of the VIM nucleus (1987)
Hamani C, Lozano AM, Memory enhancement in Alzheimer's disease (2022)
Lefaucheur JP, Aleman A, Baeken C, et al, Evidence-based guidelines for TMS (2020)
Fregni F, Simon DK, Wu A, et al, Non-invasive brain stimulation for Parkinson's disease (2020)
Hill AT, Zoghi M, Bhattacharya A, et al, Transcranial direct current stimulation for memory (2019)
Bezprozvanny I, Calcium signaling and neurodegenerative diseases (2009)
Spruston N, Pyramidal neurons: dendritic structure (2008)
Shalomov B, Yehezkiel M, Goldberg EM, Potassium channelopathies of neuronal excitability (2021)
Traynelis SF, Wollmuth LP, McBain CJ, et al, Glutamate receptor ion channels (2010)
Palop JJ, Mucke L, Synaptic depression and excitatory imbalance (2010)
Mufson EJ, Mahady L, Counts S, et al, Basal forebrain cholinergic dysfunction in AD (2022)
Wake H, Moorhouse AJ, Nabekura J, Microglia and synaptic plasticity (2011)
Verkhratsky A, Nedergaard M, Physiology of astroglia (2018)
Gulisano W, Melone M, Li Puma DD, et al, EEG power spectrum in APP/PS1 mice (2019)
Yun SP, Shin TH, Baek H, et al, α-Synuclein and network dysfunction in mouse models (2021)
de la Rosa K, Tretter E, Huber A, Electrophysiology in transgenic mouse models (2019)
Stern Y, Cognitive reserve in aging and AD (2012)
Boldrini M, Fulmore CA, Tartt AN, et al, Human hippocampal neurogenesis (2018)
Babiloni C, Del Percio C, Triggiani AI, et al, Clinical trials with neurophysiological biomarkers (2021)
Unknown, Schendan HE, Searleman A, Tyson's S. Cognitive assessment in neurodegeneration (2022)
Jack CR, Knopman DS, Jagust WJ, et al, Update on hypothetical AD biomarkers (2013)
Gilron R, Little S, Perrone R, et al, Long-term wireless streaming of neural recordings (2021)